This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...